|Articles|March 9, 2020
MYCAP CCX®: Cell Expansion of the Future
Author(s)Sartorius
-The MYCAP CCX system removes the need to perform transfers in a biosafety cabinet -Reduces the risk of contamination by eliminating significant nonaseptic procedures
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5